Latest Breaking News On - விரிவான சிகிச்சை - Page 4 : comparemela.com

Key Companies Profiled $3,188.9 Million Healthcare experts have found the single-cell multi-omics market to be one of the most rapidly evolving markets, which is predicted to grow at a CAGR of 21.16% during the forecast period, 2020-2025. The market is driven by the need for the development of an advanced solution based on single-cell technology for clinical research in various applications such as cancer, rare disease, cell biology, and synthetic biology, among others. The market is favored by the development of single-cell technology-based solutions for visualization and analysis of cell heterogeneity, tumor microenvironment, and antibody development. The gradual increase in the prevalence of oncology and rare diseases globally has furthered the single-cell multi-omics market.

United statesLaura woodNanostring technologies incBioturing incXcellbio incNamocell incBiotech companiesTakara bio incGenomics incClinical researchResearch applicationsMission bioShilps sciencesAvailability of large online data storageRarecyte incCell technology